Trexquant Investment LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$194,000
-32.9%
27,735
-12.0%
0.02%
-37.5%
Q2 2021$289,000
+112.5%
31,530
+134.6%
0.02%
+166.7%
Q3 2020$136,000
-79.6%
13,441
-83.0%
0.01%
-81.2%
Q1 2020$667,000
+152.7%
79,050
+161.9%
0.05%
+200.0%
Q4 2019$264,000
-49.4%
30,187
-37.8%
0.02%
-64.4%
Q3 2019$522,000
-79.4%
48,506
-25.9%
0.04%
-75.0%
Q1 2019$2,538,000
+125.6%
65,430
+166.7%
0.18%
+111.8%
Q3 2018$1,125,000
+78.0%
24,529
+164.3%
0.08%
+93.2%
Q1 2018$632,000
+149.8%
9,281
+220.0%
0.04%
-36.2%
Q2 2017$253,000
-57.3%
2,900
-85.0%
0.07%
-26.6%
Q4 2016$593,000
-46.2%
19,326
+17.6%
0.09%
-61.8%
Q3 2016$1,102,000
+15.2%
16,429
-49.6%
0.25%
+119.6%
Q1 2016$957,000
-24.8%
32,600
+92.9%
0.11%
+1.8%
Q3 2015$1,273,000
+356.3%
16,900
+604.2%
0.11%
+254.8%
Q2 2015$279,0002,4000.03%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,417,000$18,010,0002.24%
Palo Alto Investors LP 1,405,680$17,866,0000.87%
PFM Health Sciences, LP 2,838,376$36,076,0000.68%
TANG CAPITAL MANAGEMENT LLC 349,400$4,441,0000.60%
Capital Impact Advisors, LLC 127,029$1,615,0000.59%
Leap Investments LP 29,100$370,0000.50%
Spark Investment Management LLC 454,300$5,774,0000.40%
Partner Investment Management, L.P. 27,567$350,0000.37%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 262,945$3,342,0000.26%
Rock Springs Capital Management LP 534,400$6,792,0000.25%
View complete list of PUMA BIOTECHNOLOGY INC shareholders